GLYCARDIAL DIAGNOSTICS
GlyCardial Diagnostics is a spin-off company of the Catalan Institute of Cardiovascular Sciences (ICCC) and the Spanish National Research Council (CSIC) focused on the development of a novel in vitro diagnostic device for myocardial ischemia. The technology is based on the detection of Apo J-Glyc in blood as a biomarker for the early diagnosis of cardiac ischemia and the prediction of patient’s evolution after an ischemic event.
GLYCARDIAL DIAGNOSTICS
Industry:
Biotechnology Health Care Health Diagnostics Life Science Medical Device Pharmaceutical
Founded:
2017-09-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.glycardial.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
4.37 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Mobile Non Scaleable Content
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Advisors List
Current Employees Featured
Founder
Investors List
Horizon 2020
Horizon 2020 investment in Grant - GlyCardial Diagnostics
EIT Health
EIT Health investment in Grant - GlyCardial Diagnostics
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - GlyCardial Diagnostics
